Proactive Investors - Run By Investors For Investors

Machavert Pharmaceuticals developing drugs to target hard to fight cancers

Machavert Pharmaceuticals Jacob Staszak Jirkovsky spoke with Christine Corrado from Proactive Investors at the 11th Annual Biotech Showcase in San Francisco. The Colorado-based  bio-pharmaceutical company company develops new, first-in-class therapeutics that can harness the power of the human body to treat cancer and autoimmune diseases. The company’s primary goal is to improve the length and the quality of life of patients suffering from life threatening diseases, such as pancreatic cancer.

Meet Rockfire Resources PLC, Touchstone Exploration Inc, Mkango Resources Ltd and Salt Lake Potash Ltd at our event, London , 20 June 2019. Register here »
View full MACH profile View Profile

Machavert Pharmaceuticals Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use